Search

Your search keyword '"Teresa Elias"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Teresa Elias" Remove constraint Author: "Teresa Elias"
36 results on '"Teresa Elias"'

Search Results

1. Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism

2. Low-molecular-weight heparin beyond 12 months in patients with cancer-associated thrombosis

3. Risk of recurrent cancer-associated thrombosis after discontinuation of anticoagulant therapy

4. Differential biomarker profiles between unprovoked venous thromboembolism and cancer

6. Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis

7. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension. final safety data from the EXPERT registry

8. Prognostic Significance of Incidental Deep Vein Thrombosis in Patients with Cancer Presenting with Incidental Pulmonary Embolism

9. Current strategies for the diagnosis of pulmonary embolism

10. Clinically relevant bleeding and thrombotic events in non-cirrhotic splanchnic vein thrombosis. Long-term follow up

11. A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) Study

12. Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin

13. Intermittent pneumatic compression plus pharmacological thromboprophylaxis to prevent deep vein thrombosis

15. Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry

16. Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score

17. D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis

18. The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry

19. Towards a precision medicine in venous thromboembolism associated to lung cancer

20. Tinzaparin in cancer associated thrombosis beyond 6months: TiCAT study

21. Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'

23. The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry

24. Response

25. Unusual site thrombosis: splanchnic vein thrombosis, management in noncirrothic

26. Análisis de 3 métodos para determinar el dímero D en pacientes con sospecha de trombosis venosa profunda

27. Testing for occult cancer in patients with pulmonary embolism: Results from a screening program and a two-year follow-up survey

28. Impacto de la EPOC en la vida diaria de los pacientes. Resultados del estudio multicéntrico EIME

29. Rivaroxaban for the treatment of venous thromboembolism. A 'real-life' perspective in 103 patients

30. [Predictive Khorana's model in patients with venous thromboembolic disease and cancer]

31. Dyslipidemia as a long-term marker for survival in pulmonary embolism

32. Corrigendum to ‘Rivaroxaban for the treatment of venous thromboembolism. A 'real-life' perspective in 103 patients’ [Thrombosis Research 134 (2014) 617–621]

33. C0211: Prevalence of Metabolic Syndrome and All-Causes Mortality in Patients with Acute Symptomatic Venous Thromboembolism (VTE)

36. Colaboradores

Catalog

Books, media, physical & digital resources